15.38
-0.38(-2.41%)
Currency In USD
| Previous Close | 15.76 |
| Open | 15.86 |
| Day High | 15.93 |
| Day Low | 15.3 |
| 52-Week High | 16.66 |
| 52-Week Low | 6.38 |
| Volume | 1.94M |
| Average Volume | 1.42M |
| Market Cap | 1.48B |
| PE | -769 |
| EPS | -0.02 |
| Moving Average 50 Days | 12.02 |
| Moving Average 200 Days | 9.74 |
| Change | -0.38 |
If you invested $1000 in Avadel Pharmaceuticals plc (AVDL) 10 years ago, it would be worth $667.53 as of September 09, 2025 at a share price of $15.38. Whereas If you bought $1000 worth of Avadel Pharmaceuticals plc (AVDL) shares 5 years ago, it would be worth $2,647.16 as of September 09, 2025 at a share price of $15.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
GlobeNewswire Inc.
Sep 05, 2025 12:00 PM GMT
– 17 abstracts accepted, including one oral presentation – – Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates – – REFRESH study also highlights efficacy in those who w
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
GlobeNewswire Inc.
Sep 03, 2025 8:30 PM GMT
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7
GlobeNewswire Inc.
Jul 31, 2025 12:00 PM GMT
DUBLIN, Ireland, July 31, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at